“…Various superfluous artifacts can arise during in vitro bioassays. The relaxed substrate specificity of glycans has been observed with some glycosyltransferases. − For instance, the initiating phosphoglycosyltransferase WbaP from Salmonella enterica transfers phospho-glucose, a non-native substrate, in vitro but does not extensively catalyze this reaction in vivo . , Membrane-associated proteins are notoriously difficult to express and purify for several reasons that include unstable plasmids, toxic proteins, low yields, and inclusion body formation (i.e., misfolded proteins). , Similarly, obtaining naturally occurring lipid-linked intermediates from live cells is challenging due to competition for BP and the lack of methods available to detect these materials . Some essential cell envelope intermediates are present in detectable quantities, but it is not known if non-essential surface glycans like colanic acid are also sequentially accumulated. , Increasing the level of capsule production by modifying regulatory genes has been shown to enhance mucoid phenotypes associated with colanic acid production. ,− However, genetic disruption of exopolysaccharide biosynthesis negatively affects cell physiology. , This is explained by sequestration of BP in the form of overaccumulation of dead-end intermediates and also the reduction of free BP for peptidoglycan cell wall synthesis, an essential component of the cell envelope.…”